Photo from wikipedia
In patients with metastatic renal cell carcinoma, risk stratification according to the Memorial Sloan Kettering Cancer Center or the International Metastatic Renal Cell Carcinoma Database Consortium classification systems is a… Click to show full abstract
In patients with metastatic renal cell carcinoma, risk stratification according to the Memorial Sloan Kettering Cancer Center or the International Metastatic Renal Cell Carcinoma Database Consortium classification systems is a crucial part of clinical assessment and essential for guiding management. New research has now demonstrated that disagreement in risk-group classification is common and prognostically relevant.
Keywords:
groups metastatic;
risk;
disagreement risk;
metastatic renal;
risk groups;
cancer
Journal Title: Nature Reviews Urology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Reviews Urology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!